• News

Zejula Maintenance Therapy Extends Progression-free Survival in Advanced Ovarian Cancer Patients, Phase 3 Trial Shows

Maintenance treatment with Zejula (niraparib) extended the time without disease worsening in women with advanced ovarian cancer who had responded…

  • News

Dine Out to Help Fight Ovarian and Other Cancers, SU2C and Mastercard Urge

Foes while in opposing dugouts, two Major League Baseball¬†(MLB) managers are teaming up with Mastercard and Stand Up To Cancer…

  • News

Blood Test Ably Identifies Ovarian Cancer Prior to Surgery, Clinical Trial Planned

A blood test successfully identified ovarian cancer from circulating cells, and may enable this cancer to be detected early and…

  • News

Scientists Discover Enzyme with Key Role in Aggressive Ovarian Cancers

Scientists discovered a metabolic enzyme that adds methyl groups to other molecules, called nicotinamide N-methyltransferase, that plays an important role…

  • News

MDNA55-Interferons Combo Kills Cancer Cells, Extends Lifespan of Mice with Ovarian Cancer, Study Reports

Combining the experimental therapy MDNA55 with anti-cancer interferons (IFNs) can effectively kill cancer cells and extend the survival of mice…

  • News

Zejula-Keytruda Trial Results Warrant Further Investigation for Recurrent OC

A combination of Zejula (niraparib) and Keytruda (pembrolizumab) is well-tolerated and has promising anti-tumor activity in women with ovarian carcinoma…

  • News

Lynparza Approved in Japan as First-Line Maintenance Therapy for Advanced OC

Lynparza¬†(olaparib) has been approved in Japan as a first-line maintenance treatment for women with BRCA-mutated advanced ovarian cancer that is…

  • News

New Blood Test May Improve Ovarian Cancer Diagnosis, Study Suggests

A blood test that examines a panel of 11 specific proteins could help distinguish between benign tumors and malignant ovarian…

  • News

Testing for Multiple Biomarkers at a Time Can Increase Early Detection of OC

Testing for additional biomarkers along with the well-known biomarker CA125 can improve the detection of early-stage ovarian cancer, a new…

  • News

PARP Inhibitors Used in ‘One-two Punch’ Strategy to Kill OC Cells in Mouse Models, Study Shows

Researchers have developed a two-step approach that harnesses the aging process of cells, allowing breast and ovarian cancers to be…